Over the past 30 years, dramatic advances in the understanding of HIV infection and its therapy have transformed HIV into a highly treatable, chronic disease. With this evolution, critical questions have arisen about how basic research and clinical trials relate to clinical epidemiology and outcomes research, both in the U.S. and internationally. The goal of the Program for AIDS Clinical Research Training (PACRT), which has successfully trained leading HIV clinical investigators for the past 20 years, is to provide training in quantitative research methodologies with a focus on HIV clinical research to predoctoral PhD students and physicians at formative stages in their careers. This training has prepared both groups: to conduct clinical research of the highest quality and of direct relevance to the prevention and treatment of HIV infection. They will make important contributions to the scientific literature and successfully develop as independent investigators. In the next grant cycle, the PACRT candidates will receive two years of research training under the close supervision and mentorship of one or more of the 14 experienced program faculty members. Trainees will receive didactic training at Harvard School of Public Health or other Harvard University sites. Primary performance sites for the five post-doctoral fellows will be the Massachusetts General Hospital, Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Children's Hospital Boston and Harvard Medical School. The primary site for the two predoctoral fellows will be the Harvard School of Public Health. This program has three specific aims for its trainees: 1) To acquire a sufficient body of knowledge of quantitative methods to conduct independent research in: clinical epidemiology, clinical trials, cost-effectiveness analysis, outcomes research, and/or implementation science. 2) To foster the creation of important scientific contributions with the close and longitudinal mentorship of program faculty. 3) To develop a primary research focus and a broad understanding of the various aspects of HIV disease for novel interdisciplinary research. Relevance: PACRT has a clearly defined and unique direction among HIV T32 programs, with its focus on clinical outcomes research, and how that research interfaces with translational research, clinical trials, and health policy. This program will play a crucial role in training the next generation of highly successful investigators to address the complex issues arising today in HIV clinical research.

Public Health Relevance

The Program for AIDS Clinical Research Training (PACRT) continues to develop and launch a new cadre of independent scientists studying a broad array of clinical and public health issues in HIV disease using the tools of clinical epidemiology, outcomes research, and cost-effectiveness analysis. These young investigators focus time, energy and training on critical and evolving questions at the forefront of HIV clinical management throughout the world.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI007433-22
Application #
8495203
Study Section
Acquired Immunodeficiency Syndrome Research Review Committee (AIDS)
Program Officer
Sharma, Opendra K
Project Start
1992-09-30
Project End
2017-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
22
Fiscal Year
2013
Total Cost
$432,257
Indirect Cost
$28,810
Name
Harvard University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Zash, Rebecca; Souda, Sajini; Chen, Jennifer Y et al. (2016) Reassuring Birth Outcomes With Tenofovir/Emtricitabine/Efavirenz Used for Prevention of Mother-to-Child Transmission of HIV in Botswana. J Acquir Immune Defic Syndr 71:428-36
Rough, Kathryn; Bateman, Brian T; Patorno, Elisabetta et al. (2016) Suppression of Substance Abuse Claims in Medicaid Data and Rates of Diagnoses for Non-Substance Abuse Conditions. JAMA 315:1164-6
Subbaraman, Ramnath; Nathavitharana, Ruvandhi R; Satyanarayana, Srinath et al. (2016) The Tuberculosis Cascade of Care in India's Public Sector: A Systematic Review and Meta-analysis. PLoS Med 13:e1002149
Caniglia, Ellen C; Patel, Kunjal; Huo, Yanling et al. (2016) Atazanavir exposure in utero and neurodevelopment in infants: a comparative safety study. AIDS 30:1267-78
Reddy, Krishna P; Bajwa, Ednan K; Parker, Robert A et al. (2016) Relationship Between Upper Respiratory Tract Influenza Test Result and Clinical Outcomes Among Critically Ill Influenza Patients. Open Forum Infect Dis 3:ofw023
Aibana, Omowunmi; Acharya, Xeno; Huang, Chuan-Chin et al. (2016) Nutritional Status and Tuberculosis Risk in Adult and Pediatric Household Contacts. PLoS One 11:e0166333
Abuelezam, Nadia N; McCormick, Alethea W; Fussell, Thomas et al. (2016) Can the Heterosexual HIV Epidemic be Eliminated in South Africa Using Combination Prevention? A Modeling Analysis. Am J Epidemiol 184:239-48
Diakite, Ibrahim; Mooring, Eric Q; Velásquez, Gustavo E et al. (2016) Novel Ordered Stepped-Wedge Cluster Trial Designs for Detecting Ebola Vaccine Efficacy Using a Spatially Structured Mathematical Model. PLoS Negl Trop Dis 10:e0004866
Bebell, Lisa M; Ayebare, Arnold; Boum 2nd, Yap et al. (2016) Prevalence and correlates of MRSA and MSSA nasal carriage at a Ugandan regional referral hospital. J Antimicrob Chemother :
Bebell, Lisa M; Siedner, Mark J; Musinguzi, Nicholas et al. (2016) Trends in one-year cumulative incidence of death between 2005 and 2013 among patients initiating antiretroviral therapy in Uganda. Int J STD AIDS :

Showing the most recent 10 out of 148 publications